Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 126-150 of 167 matching filings.

Per page
25
Current page
6
8-K File 001-37722

8-K

Filing date
21 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
11 Dec 2018
Reporting date
11 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
11 Dec 2018
Reporting date
11 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
29 Nov 2018
Reporting date
26 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
22 Oct 2018
Reporting date
21 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
17 Oct 2018
Reporting date
17 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
10 Oct 2018
Reporting date
08 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
04 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
23 Jul 2018
Reporting date
18 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
16 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
08 Jun 2018
Reporting date
07 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
08 May 2018
Reporting date
08 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
19 Apr 2018
Reporting date
18 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

FORM 8-K

Filing date
17 Apr 2018
Reporting date
17 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
16 Apr 2018
Reporting date
16 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
16 Apr 2018
Reporting date
13 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
12 Apr 2018
Reporting date
12 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
12 Apr 2018
Reporting date
11 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
26 Mar 2018
Reporting date
26 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

2017 YE 8-K

Filing date
13 Mar 2018
Reporting date
13 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
07 Sep 2017
Reporting date
03 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .